About Cambrian BioPharma
Cambrian BioPharma is a company based in Brooklyn (United States) founded in 2019 by James Peyer.. Cambrian BioPharma has raised $211.46 million across 4 funding rounds from investors including Galaxy, Anthos Capital and Apeiron Investment Group. Cambrian BioPharma offers products and services including Therapeutics. Cambrian BioPharma operates in a competitive market with competitors including PPD, Medicus Pharma, H.U. Group Holdings, DM Clinical and Excelsus Statistics, among others.
- Headquarter Brooklyn, United States
- Founders James Peyer
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Avgsf - Cambrian Bio 2021, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$211.46 M (USD)
in 4 rounds
-
Latest Funding Round
$23.02 M (USD), Series C
Jun 02, 2023
-
Investors
Galaxy
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cambrian BioPharma
Cambrian BioPharma offers a comprehensive portfolio of products and services, including Therapeutics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drugs targeting chronic diseases through aging biology research.
Unlock access to complete
Unlock access to complete
Funding Insights of Cambrian BioPharma
Cambrian BioPharma has successfully raised a total of $211.46M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $23.02 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $23.0M
-
First Round
First Round
(17 Jan 2020)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Series C - Cambrian BioPharma | Valuation |
investors |
|
| Oct, 2021 | Amount | Series C - Cambrian BioPharma | Valuation | Anthos Capital , SALT Fund | |
| May, 2021 | Amount | Series C - Cambrian BioPharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cambrian BioPharma
Cambrian BioPharma has secured backing from 8 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Galaxy, Anthos Capital and Apeiron Investment Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in innovative consumer and technology companies based in Santa Monica.
|
Founded Year | Domain | Location | |
|
Venture capital firm backed by Christian Angermayer
|
Founded Year | Domain | Location | |
|
Future Ventures is focused on early-stage venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cambrian BioPharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cambrian BioPharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cambrian Biopharma Comparisons
Competitors of Cambrian BioPharma
Cambrian BioPharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PPD, Medicus Pharma, H.U. Group Holdings, DM Clinical and Excelsus Statistics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
CRO providing diversified clinical development services
|
|
| domain | founded_year | HQ Location |
Clinical stage, multi-strategy holding company focused on investing in and accelerating novel therapies in the biotechnology and life sciences industry
|
|
| domain | founded_year | HQ Location |
Provider of clinical testing, diagnostics, and healthcare services. This entity offers a range of services encompassing laboratory testing and related services, in-vitro diagnostics, healthcare-related services, and research and development. Their activities include supporting research in clinical laboratory medicine, fostering technological advancements, and contributing to the overall progress of medical science and healthcare technology. They also engage in intellectual property activities and have initiatives addressing public health concerns.
|
|
| domain | founded_year | HQ Location |
Conducts Phase I-IV clinical trials connecting patients with physicians for medical research.
|
|
| domain | founded_year | HQ Location |
CRO focused on clinical development for dermatology drugs, site management, and patient recrutiment services
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cambrian Biopharma
Frequently Asked Questions about Cambrian BioPharma
When was Cambrian BioPharma founded?
Cambrian BioPharma was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Cambrian BioPharma located?
Cambrian BioPharma is headquartered in Brooklyn, United States. It is registered at Brooklyn, New York, United States.
Who is the current CEO of Cambrian BioPharma?
James Peyer is the current CEO of Cambrian BioPharma. They have also founded this company.
Is Cambrian BioPharma a funded company?
Cambrian BioPharma is a funded company, having raised a total of $211.46M across 4 funding rounds to date. The company's 1st funding round was a Series C of $28.43M, raised on Jan 17, 2020.
What does Cambrian BioPharma do?
Cambrian BioPharma was established in 2019 and is based in Brooklyn, United States. Operations are centered on the biopharmaceutical sector, where medicines and therapies are developed to address medical needs. Research and development activities are led by Founder and CEO James Peyer. The companys domain, cambrianbio.com, supports its work in advancing therapeutic solutions across various health domains.
Who are the top competitors of Cambrian BioPharma?
Cambrian BioPharma's top competitors include PPD, Medicus Pharma and H.U. Group Holdings.
What products or services does Cambrian BioPharma offer?
Cambrian BioPharma offers Therapeutics.
Who are Cambrian BioPharma's investors?
Cambrian BioPharma has 8 investors. Key investors include Galaxy, Anthos Capital, Apeiron Investment Group, Future Ventures, and Moore Capital Management.